Projekt

A Phase 1b/2 Multicenter, Open-label, Expansion Study to As-sess the Safety and Efficacy of AMG 420 as Monotherapy in Subjects With Relapsed and/or Refractory Multiple Myeloma

Automatisch geschlossen · 2019 bis 2020

Driessen Christoph, Silzle Tobias